ABVC BioPharma, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets
ABVC BioPharma, Inc. (ECOC) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets of $6.71 million as of 2023-12-31, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Asset
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets · last filed 2026-08-12
- 2023-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $6.71M.
- 2019-02-08: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $1.27M.
- 2018-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $896.31K.
- 2014-09-25: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $10.00K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets |
|---|---|
| 2023-12-31 | $6.71M 10-Q · filed 2026-08-12 |
| 2019-02-08 | $1.27M 10-Q · filed 2022-11-14 |
| 2018-12-31 | $896.31K 10-K · filed 2019-04-15 |
| 2014-09-25 | $10.00K 10-K · filed 2015-11-27 |